The loss of half the U.S. supply of influenza vaccine due to contamination has created a critical shortage. Dose-sparing strategies that use intradermal delivery of vaccines may be one approach to ...
NES ZIONA, Israel and SHANGHAI, China, Feb. 7, 2022 /PRNewswire/ -- Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to ...
The global Intradermal Injection Market is expected to exceed an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% projected from 2022 to 2032.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback